Pharmacokinetic variability of extended interval tobramycin in burn patients
Authors:
- David BraccoDBDavid Bracco
- Christine LandryCLChristine Landry
- Marc-Jacques DuboisMDMarc-Jacques Dubois
- Philippe EggimannPEPhilippe Eggimann
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Increased amikacin dosage requirements in burn patients receiving a once-daily regimenInternational Journal of Antimicrobial Agents, 2006
- Gentamicin and Tobramycin Binding to Human Serum In VitroJournal of Analytical Toxicology, 2004
- Pharmacodynamics and dosing of aminoglycosidesInfectious Disease Clinics of North America, 2003
- Pharmacokinetic Model for Tobramycin in Acinetobacter MeningitisAnnals of Pharmacotherapy, 2002
- Population Pharmacokinetics of Aminoglycosides in Critically Ill Trauma Patients on Once-Daily RegimensThe Journal of Trauma: Injury, Infection, and Critical Care, 2000
- Pharmacokinetics of antibiotics in burn patientsJournal of Antimicrobial Chemotherapy, 1999
- Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading doseSurgery, 1998
- 2 IMPACT OF GOAL-ORIENTED MODEL-BASED TDM OF AMINOGLYCOSIDES ON CLINICAL OUTCOMETherapeutic Drug Monitoring, 1997
- Wide Variation in Single, Daily-Dose Aminoglycoside Pharmacokinetics in Patients with Burn InjuriesJournal of Burn Care & Rehabilitation, 1997
- A controlled trial of the cost benefit of computerized bayesian aminoglycoside administrationClinical Pharmacology & Therapeutics, 1991